John C. Gutheil
Director Ejecutivo en Sciquus, Inc. .
Perfil
John C.
Gutheil is currently the President & Chief Executive Officer at Sciquus, Inc. He was previously the Chief Executive Officer at Proacta, Inc. from 2006 to 2011.
He also held positions at Vical, Inc., Sidney Kimmel Cancer Center, Favrille, Inc., the University of Maryland, and Aphelion Capital LLC.
Dr. Gutheil received his undergraduate degree from the University of California San Diego in 1979 and his doctorate from The Medical College of Wisconsin, Inc.
Cargos activos de John C. Gutheil
Empresas | Cargo | Inicio |
---|---|---|
Sciquus, Inc. | Director Ejecutivo | 01/01/2014 |
Antiguos cargos conocidos de John C. Gutheil.
Empresas | Cargo | Fin |
---|---|---|
Aphelion Capital LLC
Aphelion Capital LLC Investment ManagersFinance Aphelion Capital LLC (Aphelion Capital) is a venture capital firm founded in 2005 by Ned Scheetz and Rodney Altman. The firm is headquartered in Mill Valley, California. | Corporate Officer/Principal | 30/06/2009 |
University of Maryland | Corporate Officer/Principal | - |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Director Técnico/Científico/I+D | - |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - |
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Director Ejecutivo | - |
Formación de John C. Gutheil.
University of California San Diego | Undergraduate Degree |
The Medical College of Wisconsin, Inc. | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Favrille, Inc. | Health Technology |
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Aphelion Capital LLC
Aphelion Capital LLC Investment ManagersFinance Aphelion Capital LLC (Aphelion Capital) is a venture capital firm founded in 2005 by Ned Scheetz and Rodney Altman. The firm is headquartered in Mill Valley, California. | Finance |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Health Services |
Sciquus, Inc. |
- Bolsa de valores
- Insiders
- John C. Gutheil